Medical Radiology and Radiation Safety. 2021. Vol. 66. № 5. P. 101–104

Clinical Case of Treatment of Stage IV Esophageal Cancer

I.A. Strikanova, Ju.V. Gumeneckaja, S.O. Dzhabrailova, K.S. Makarova, T.A. Kireeva

A.F. Tsyb Medical Radiological Research Center, Obninsk, Russia

Contact person: Irina Alecsandrovna Strikanova : This email address is being protected from spambots. You need JavaScript enabled to view it.


In 2018 in Russian Federation more than 500 thousand new cases of cancer were found, including 8000 cases with malignant tumors of esophagus and more than 30 % of patients have the IV stage.

Esophageal cancer takes the 6-th place in death causes connected to cancer in the world and it is still one of the main global problems in medical care. Oncologists face the problem of the most difficult choice in treatment tactics for spread stages of disease. In this situation it is recommended to provide combined treatment (surgery, neoadjuvant and adjuvant chemotherapy). 

Definitive radiotherapy or chemoradiotherapy (without surgery) is used for patients with unrespectable esophageal tumor. 

In this article we present clinical case of successful treatment of a patient with metastatic esophageal cancer. The patient got chemoradiotherapy in 2017 and after control checkup in November 2019 remission was registered. After provided treatment stopping of pain syndrome and dysphagia, food passage through esophagus was restored. The patient notes good life quality, he is physically active and socially adapted. 

Key words: esophageal cancer, radiotherapy, chemoradiotherapy, palliative treatment 

For citation: Strikanova IA, Gumeneckaja JuV, Dzhabrailova SO, Makarova KS, Kireeva TA. Clinical Case of Treatment of Stage IV Esophageal Cancer. Medical Radiology and Radiation Safety. 2021;66(5):101-104.

DOI: 10.12737/1024-6177-2021-66-5-101-104


1. Kaprin AD, Starinskiy VV, Petrova GV. State of Cancer Care in Russia in 2018. Moscow, P. Hertsen Moscow Oncology Research Institute Publ., 2019. P. 27-31 (In Russian).

2. Bray F, Ferlay J, Soerjomataram I, et al. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2018;68;6:394–424.

3. Smyth EC, Lagergren J, Fitzgerald RC, et al. Oesophageal Cancer. Nature Reviews Disease Primers. 2017;3:17-48.

4. Alsop BR, Sharm P. Esophageal Cancer // Gastroenterology Clinics of North America. 2016;45;3:399–412.

5. Tryakin AA, Besova NS, Volkov NM, et al. Practical Recommendations for Drug Treatment of Esophageal Cancer and Esophageal-Gastric Junction. Malignant Tumors: Practical Recommendations RUSSCO. 2018;8:260–272 (In Russian).

6. Tham JE, Tharian B, Allen PB, et al. Oesophageal Stents for Potentially Curable Oesophageal Cancer–A Bridge to Surgery? Ulster Medical Journal. 2019;88;1:10–14.

7. Hulshof MCCM, van Laarhoven HWM. Chemoradiotherapy in Tumours of the Oesophagus and Gastro-Oesophageal Junction. Best Practice & Research Clinical Gastroenterology. 2016;30:551-563.

8. Greally M, Ilson DH. Neoadjuvant Therapy for Esophageal Cancer: who, when, and what? Cancer. 2018;124:4276–4278.

 PDF (RUS) Full-text article (in Russian)


Conflict of interest. The authors declare no conflict of interest.

Financing. The study had no sponsorship.

Contribution. Article was prepared with equal participation of the authors.

Article received: 23.12.2020. 

Accepted for publication: 20.01.2021.